Title:
THE USE OF RETINOID RECEPTOR ANTAGONISTS IN THE TREATMENT OF PROSTATE CARCINOMA
Document Type and Number:
WIPO Patent Application WO2001007028
Kind Code:
A3
Abstract:
The present invention relates to methods for treating prostate cancer comprising administering a therapeutically effective amount of a retinoid receptor antagonist. In addition, the present invention provides methods of inhibiting the growth of a prostate carcinoma cell or tumor, the method comprising contacting the cell or tumor with an effective amount of a retinoid receptor antagonist.
Inventors:
CHANDRARATNA ROSHANTHA A
BROWN GEOFFREY
BROWN GEOFFREY
Application Number:
PCT/US2000/019849
Publication Date:
August 30, 2001
Filing Date:
July 21, 2000
Export Citation:
Assignee:
ALLERGAN SALES INC (US)
International Classes:
A61K31/352; A61K31/382; (IPC1-7): A61K31/352; A61K31/382; A61P35/00
Domestic Patent References:
| WO1999033821A1 | 1999-07-08 | |||
| WO1997024348A1 | 1997-07-10 |
Foreign References:
| US5773594A | 1998-06-30 | |||
| US5739338A | 1998-04-14 | |||
| US5728846A | 1998-03-17 | |||
| US5919970A | 1999-07-06 | |||
| US5808124A | 1998-09-15 | |||
| US5763635A | 1998-06-09 |
Download PDF:
Previous Patent: PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL DISEASES
Next Patent: Substituted guanidines and the use thereof
Next Patent: Substituted guanidines and the use thereof